332
Participants
Start Date
December 18, 2018
Primary Completion Date
October 8, 2020
Study Completion Date
October 8, 2020
Roflumilast
Roflumilast cream 0.3% for topical application
Arcutis Clinical Site 22, New York
Arcutis Clinical Site 15, Pittsburgh
Arcutis Clinical Site 31, Norfolk
Arcutis Clinical Site 14, High Point
Arcutis Clinical Site 16, Sanford
Arcutis Clinical Site 12, Miami
Arcutis Clinical Site 21, Louisville
Arcutis Clinical Site 39, Bexley
Arcutis Clinical Site 34, Clinton Township
Arcutis Clinical Site 33, Detroit
Arcutis Clinical Site 20, Fridley
Arcutis Clinical Site 37, Houston
Arcutis Clinical Site 13, Houston
Arcutis Clinical Site 24, Webster
Arcutis Clinical Site 19, College Station
Arcutis Clinical Site 23, San Antonio
Arcutis Clinical Site 35, Beverly Hills
Arcutis Clinical Site 27, Santa Monica
Arcutis Clinical Site 29, Northridge
Arcutis Clinical Site 28, San Diego
Arcutis Clinical Site 18, Surrey
Arcutis Clinical Site 11, Surrey
Arcutis Clinical Site 38, Winnipeg
Arcutis Clinical Site 10, Ajax
Arcutis Clinical Site 25, London
Arcutis Clinical Site 26, Markham
Arcutis Clinical Site 32, Oakville
Arcutis Clinical Site 17, Peterborough
Arcutis Clinical Site 30, Waterloo
Arcutis Clinical Site 36, Windsor
Lead Sponsor
Arcutis Biotherapeutics, Inc.
INDUSTRY